Embryonic hepatocyte transplantation for hepatic cirrhosis: Efficacy and mechanism of action

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

373

HTML

4424

Figures (1-9)

148

Tables (1-8)

177

Sum=5122

Jan 28, 2012 (publication date) through May 10, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 28, 2012; 18(4): 309-322
Published online Jan 28, 2012. doi: 10.3748/wjg.v18.i4.309

Table 5 Effects of hepatocyte transplantation on serum mar-ker levels (mean ± SD, n = 10)

^bP < 0.01 vs the normal control group;

^dP < 0.01 vs the untreated cirrhotic group. ET: Endothelin; AFP: α-fetoprotein.

Citation: Bin WT, Ma LM, Xu Q, Shi XL. Embryonic hepatocyte transplantation for hepatic cirrhosis: Efficacy and mechanism of action. World J Gastroenterol 2012; 18(4): 309-322
URL: https://www.wjgnet.com/1007-9327/full/v18/i4/309.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i4.309